] Filters: Author is Mandal, M. [Clear All Filters]
"Targeting of EGFR, VEGFR2 and Akt by engineered dual drug encapsulated mesoporous silica-gold nanoclusters sensitizes tamoxifen-resistant breast cancer",
ACS Molecular Pharmaceutics, vol. 15, issue 7, pp. 2698–2713, doi:10.1021/acs.molpharmaceut.8b00218, 2018.
"Engineering Silk Biomaterials for Cancer Therapy",
Tissue Engineering Part A, vol. 23, issue S1, pp. S-1-S-159, doi:10.1089/ten.tea.2017.29003.abstracts, 2017.
